Vimarsana
Biggest News Aggregation in the World

Bioscience Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioscience Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioscience Division Today - Breaking & Trending Today

N4 Pharma collaborates with SRI International to combine Nuvec and FOX Three MGS technology - Vimarsana News

N4 Pharma collaborates with SRI International to combine Nuvec and FOX Three MGS technology

N4 Pharma Plc partners with SRI International to combine Nuvec® with FOX Three MGS, aiming to enhance nucleotide therapies for cancer and vaccines.

Collaboration Agreement with SRI International Inc | Company Announcement - Vimarsana News

Collaboration Agreement with SRI International Inc | Company Announcement

Investegate announcements from Collaboration Agreement with SRI International Inc

Tosoh to Increase Production Capacity of Separation and Purification Media - Pharmaceutical Business review - Vimarsana News

Tosoh to Increase Production Capacity of Separation and Purification Media - Pharmaceutical Business review

Tosoh Corporation has announced it will increase the production capacity of separation and purification media TOYOPEARL®and TSKgel® PW at its Nanyo Complex (Shunan City, Yamaguchi Prefecture) in response to

Tosoh to increase production capacity for separation and purification media - Chemical Engineering - Vimarsana News

Tosoh to increase production capacity for separation and purification media - Chemical Engineering

(Page 1) Tosoh Corp. (Tokyo) has announced it will increase the production capacity of separation and purification media TOYOPEARL and TSKgel PW at its Nanyo

Grifols (NASDAQ:GRFS) Downgraded to "Sell" at Zacks Investment Research - Vimarsana News

Grifols (NASDAQ:GRFS) Downgraded to "Sell" at Zacks Investment Research

Grifols (NASDAQ:GRFS – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and […]